CADAMURO, MASSIMILIANO
 Distribuzione geografica
Continente #
NA - Nord America 4.933
EU - Europa 325
AS - Asia 187
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
SA - Sud America 1
Totale 5.451
Nazione #
US - Stati Uniti d'America 4.933
CN - Cina 175
FI - Finlandia 79
IT - Italia 75
SE - Svezia 54
DE - Germania 37
GB - Regno Unito 31
UA - Ucraina 22
IE - Irlanda 10
IN - India 7
NL - Olanda 5
GR - Grecia 4
AT - Austria 3
EU - Europa 3
CH - Svizzera 2
FR - Francia 2
HK - Hong Kong 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BE - Belgio 1
BR - Brasile 1
NZ - Nuova Zelanda 1
SG - Singapore 1
Totale 5.451
Città #
Fairfield 914
Woodbridge 646
Houston 476
Ashburn 387
Chandler 373
Wilmington 338
Cambridge 324
Seattle 319
Ann Arbor 291
Princeton 100
San Diego 91
Jacksonville 87
Medford 79
Des Moines 62
Helsinki 38
Beijing 37
Nanjing 37
Boardman 26
Padova 21
Roxbury 18
Jinan 15
London 13
Nanchang 12
Shenyang 10
Dublin 9
Falls Church 9
Hebei 9
Redwood City 8
Haikou 7
Norwalk 7
Rome 7
Cagliari 6
Zhengzhou 6
Dalmine 5
Hangzhou 5
Jiaxing 4
Milan 4
New York 4
Ogden 4
Pune 4
Taiyuan 4
Borås 3
Changsha 3
Guangzhou 3
Kunming 3
Los Angeles 3
Munich 3
Rockville 3
Shanghai 3
Tianjin 3
Venezia 3
Aprilia 2
Atlanta 2
Auburn Hills 2
Bangkok 2
Dearborn 2
Fort Worth 2
Fremont 2
Hong Kong 2
Kharkiv 2
Ningbo 2
Perugia 2
Portogruaro 2
Prescot 2
San Francisco 2
Sankt Margrethen 2
Taizhou 2
Tappahannock 2
Vedelago 2
Vienna 2
Wuhan 2
Acton 1
Avellino 1
Brussels 1
Callan 1
Chapel Hill 1
Charlotte 1
Chicago 1
Chiswick 1
Chiuppano 1
Chongqing 1
Cinisello Balsamo 1
Como 1
Denville 1
Groningen 1
Grottaferrata 1
Hefei 1
Heidelberg 1
Indiana 1
Isola Vicentina 1
Kilburn 1
Lanzhou 1
Lappeenranta 1
Las Vegas 1
Lower Hutt 1
Miami Beach 1
Modena 1
Mumbai 1
Nürnberg 1
Sacile 1
Totale 4.915
Nome #
Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumor-stroma interactions 160
Olfactory neuroepithelium alterations and cognitive correlates in schizophrenia 137
Animal models of cholestasis: An update on inflammatory cholangiopathies 135
Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma. 131
Platelet-Derived Growth Factor-D Enables Liver Myofibroblasts to Promote Tumor Lymphangiogenesis in Cholangiocarcinoma 129
ERK1/2-Dependent Vascular Endothelial Growth Factor Signaling Sustains Cyst Growth in Polycystin-2 Defective Mice 126
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C. 117
Analysis of Liver Repair Mechanisms in Alagille Syndrome and Biliary Atresia Reveals a Role for Notch Signaling. 115
Low dose paclitaxel reduces S100A4 nuclear import to inhibit invasion and hematogenous metastasis of cholangiocarcinoma 113
Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion. 112
The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma 111
Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation 110
Isolated idiopathic bile ductular hyperplasia in patients with persistently abnormal liver function tests 107
Fibroinflammatory Liver Injuries as Preneoplastic Condition in Cholangiopathies 106
Personalized molecular targeted therapy for hepatocellular carcinoma in the era of genome sequencing 100
Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma? 100
Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization. 99
Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis 98
APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe-/- atherosclerotic mice 96
The patient presenting with isolated hyperbilirubinemia. 95
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice. 94
Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development. 94
Diagnostic and prognostic biomarkers in cholangiocarcinoma 92
Emerging Concepts in Biliary Repair and Fibrosis 91
Autocrine and paracrine mechanisms promoting chemoresistance in cholangiocarcinoma 90
SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM 87
SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM 87
Animal models of cholangiocarcinoma: What they teach us about the human disease 85
Precision medicine in cholangiocarcinoma 84
Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness 83
β-Catenin and interleukin-1β–dependent chemokine (C-X-C motif) ligand 10 production drives progression of disease in a mouse model of congenital hepatic fibrosis 83
Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development 81
Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases 80
PKA-DEPENDENT P-SER- 675 β-CATENIN PHOSPHORYLATION INCREASES CHOLANGIOCYTE MOTILITY IN PKHD1DEL4/DEL4 MICE, A MODEL OF FIBROPOLYCYSTIC LIVER DISEASES CAUSED BY DEFECTIVE FIBROCYSTIN FUNCTION 78
Incretin-based treatment in type 2 diabetes mellitus and risk of cholangiocarcinoma: Is it only adverse drug effect? 78
MONOCYTE/MACROPHAGE PERIBILIARY RECRUITMENT BY PKHD1-DEFECTIVE CHOLANGIOCYTES INDUCES EXPRESSION OF aVb6 INTEGRIN ON BILIARY CYSTS VIA TGF-Β1 AND TNF-Α IN CONGENITAL HEPATIC FIBROSIS 71
Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium 68
MONOCYTE/MACROPHAGE PERIBILIARY RECRUITMENT BY PKHD1-DEFECTIVE CHOLANGIOCYTES INDUCES EXPRESSION OF aVb6 INTEGRIN ON BILIARY CYSTS VIA TGF-Β1 AND TNF-Α IN CONGENITAL HEPATIC FIBROSIS 67
A ploidy increase promotes sensitivity of glioma stem cells to aurora kinases inhibition 67
SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM 66
Animal models for cystic fibrosis liver disease (CFLD) 66
The healthy biliary tree: Cellular and immune biology 66
Molecular mechanisms driving cholangiocarcinoma invasiveness: An overview 64
Liver Matrix in Benign and Malignant Biliary Tract Disease 63
Cholangiocyte biology as relevant to cystic liver diseases 61
Necroptosis in Cholangiocarcinoma 56
Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis 51
Patogenesi molecolare delle malattie disembriogenetiche dell'epitelio bibliare 51
Anti-Inflammatory and Pro-Regenerative Effects of Hyaluronan-Chitlac Mixture in Human Dermal Fibroblasts: A Skin Ageing Perspective 51
Effects of angiogenic factor overexpression by cholangiocytes in polycystic liver diseases 49
LEUKAEMIA INHIBITORY FACTOR PROTECTS CHOLANGIOCARCINOMA CELLS FROM CYTOTOXICITY VIA MCL-1 46
Benign biliary neoplasms and biliary tumor precursors 46
null 42
LEUKAEMIA INHIBITORY FACTOR PROTECTS CHOLANGIOCYTES FROM CYTOTOXICITY IN CHOLANGIOCARCINOMA 41
Β-CATENIN-MEDIATED CXCL1 AND CXCL10 SECRETION BY FIBROCYSTIN-DEFECTIVE CHOLANGIOCYTES REGULATES PERIBILIARY RECRUITMENT OF FIBROCYTES IN CONGENITAL HEPATIC FIBROSIS 41
Unveiling the Role of Tumor Reactive Stroma in Cholangiocarcinoma: an Opportunity for New Therapeutic Strategies 40
Cholangiocarcinoma 40
Role of angiogenesis and angiogenetic factors for cholangiocyte growth 39
CXCL1 AND CXCL10 SECRETION BY FIBROCISTIDEFECTIVE CHOLANGIOCYTES RECRUITS PERIBILIARY FIBROCYTES IN CONGENITAL HEPATIC FIBROSIS 39
Congenital Cystic Lesions of the Biliary Tree 39
PKA-DEPENDENT P-SER-675-CATENIN PHOSPHORYLATION INCREASES CHOLANGIOCYTE MOTILITY IN A MOUSE MODEL OF FIBROPOLYCYSTIC LIVER DISEASES 35
Fibrocystic liver disease: Novel concepts and translational perspectives 35
Cholangiocarcinoma 35
The emerging role of macrophages in chronic cholangiopathies featuring biliary fibrosis: an attractive therapeutic target for orphan diseases 31
Colestasi intraepatica 30
Dysregulation of the Scribble/YAP/β-catenin axis sustains the fibroinflammatory response in a PKHD1-/- mouse model of congenital hepatic fibrosis 30
Targeted therapies for extrahepatic cholangiocarcinoma: preclinical and clinical development and prospects for the clinic 29
New insights on the role of vascular endothelial growth factor in biliary pathophysiology 29
RAC1 AND CDC42 ACTIVATION REGULATES PDGF‐D MEDIATED CAF RECRUITMENT BY CANCER CELLS IN CHOLANGIOCARCINOMA 28
Colangite Sclerosante Primitiva 26
Cholangiocyte Biology and Pathobiology 26
Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression 26
PKA dependent p-Ser-675β-catenin, a novel signaling defect in a mouse model of Congenital Hepatic Fibrosis 25
Obeticholic acid reduces biliary and hepatic matrix metalloproteinases activity in rat hepatic ischemia/reperfusion injury 25
Illuminate TWEAK/Fn14 pathway in intrahepatic cholangiocarcinoma: Another brick in the wall of tumor niche 25
Cirrosi Biliare Primitiva 23
Colestasi Genetiche 23
The Neglected Role of Bile Duct Epithelial Cells in NASH 19
Molecular pathology analysis of sars-cov-2 in syncytiotrophoblast and hofbauer cells in placenta from a pregnant woman and fetus with covid-19 18
Unmet needs in basic and translational research in Cholangiocarcinoma 14
Molecular pathogenesis of intrahepatic cholangiocarcinoma: from inflammation and cholestasis to a microenvironment-driven tumor 13
How to mimic a histological sample slide for RNAscope TM applications from BAL cytological specimens 12
Inflammatory pathways and cholangiocarcioma risk mechanisms and prevention 11
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models 8
Evidence of vertical transmission of SARS-CoV-2 and interstitial pneumonia in second trimester twin stillbirth in asymptomatic woman. Case report and review of the literature 8
Tumor microenvironment and immunology of cholangiocarcinoma 8
Notch signaling and progenitor/ductular reaction in steatohepatitis 7
The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity 7
Nephrosphere-Derived Cells Are Induced to Multilineage Differentiation when Cultured on Human Decellularized Kidney Scaffolds 7
Advanced endoscopy meets molecular diagnosis of cholangiocarcinoma 6
Resveratrol impairs glioma stem cells proliferation and motility by modulating the wnt signaling pathway 6
The Landscape of HNF1B Deficiency: A Syndrome Not Yet Fully Explored 4
Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "reactive" Biliary Epithelial Phenotype 3
New case of syncytial giant-cell variant of hepatocellular carcinoma in a pediatric patient with HNF1B deficiency: does it fit with the syndrome? 1
Totale 5.547
Categoria #
all - tutte 20.346
article - articoli 18.237
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.750
Totale 40.333


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019359 0 0 0 0 0 0 0 0 0 0 196 163
2019/20201.307 163 78 11 72 137 94 119 132 207 159 89 46
2020/20211.017 78 68 141 55 47 33 15 173 127 82 151 47
2021/20221.170 24 134 146 58 79 70 71 109 119 27 103 230
2022/2023741 171 73 15 94 114 100 2 50 85 2 30 5
2023/2024233 12 60 36 31 21 23 17 12 15 4 2 0
Totale 5.547